Trial intelligence / Profile preview

Age-Related Effects of THC (ART)

NCT04294966Phase 1Completed

Sponsor
University of Chicago
Start
Mar 2020
Primary completion
May 2021
Modality
Small Molecules
Countries
1
01

Overview

Phase 1, randomised, double-blind trial of dronabinol, sponsored by University of Chicago. Primary endpoint: Profile of Mood States at 3 weeks. Started Mar 2020; status: completed.

02

Drugs

dronabinol

Beyond the preview

Go deeper on NCT04294966.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT04294966.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call